CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. Low bargaining power of suppliers
3.3.2. Low threat of new entrants
3.3.3. Low threat of substitutes
3.3.4. Low intensity of rivalry
3.3.5. Low bargaining power of buyers
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Technological advancements in live cell imaging systems
3.4.1.2. Rise in adoption of high-content screening in drug discovery
3.4.1.3. Rise in new product launches in live cell imaging
3.4.2. Restraints
3.4.2.1. High cost and maintenance of live cell imaging systems
3.4.3. Opportunities
3.4.3.1. Growth in opportunities in emerging markets
CHAPTER 4: LIVE CELL IMAGING MARKET, BY PRODUCT TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Instruments
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.2.4. Instruments Live Cell Imaging Market by Type of Instrument
4.3. Accessories and Consumables
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.4. Software
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
CHAPTER 5: LIVE CELL IMAGING MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Cell Biology
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Stem Cells
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Developmental Biology
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
5.5. Drug Discovery
5.5.1. Key market trends, growth factors and opportunities
5.5.2. Market size and forecast, by region
5.5.3. Market share analysis by country
CHAPTER 6: LIVE CELL IMAGING MARKET, BY TECHNOLOGY
6.1. Overview
6.1.1. Market size and forecast
6.2. Time-lapse Microscopy
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Fluorescence Resonance Energy Transfer (FRET)
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.4. Fluorescence Recovery After Photobleaching (FRAP)
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis by country
6.5. High-Content Screening (HCS)
6.5.1. Key market trends, growth factors and opportunities
6.5.2. Market size and forecast, by region
6.5.3. Market share analysis by country
6.6. Other Technologies
6.6.1. Key market trends, growth factors and opportunities
6.6.2. Market size and forecast, by region
6.6.3. Market share analysis by country
CHAPTER 7: LIVE CELL IMAGING MARKET, BY END USER
7.1. Overview
7.1.1. Market size and forecast
7.2. Pharmaceutical and Biotechnological Companies
7.2.1. Key market trends, growth factors and opportunities
7.2.2. Market size and forecast, by region
7.2.3. Market share analysis by country
7.3. Academic and Research Institutes
7.3.1. Key market trends, growth factors and opportunities
7.3.2. Market size and forecast, by region
7.3.3. Market share analysis by country
7.4. Contract Research Organizations
7.4.1. Key market trends, growth factors and opportunities
7.4.2. Market size and forecast, by region
7.4.3. Market share analysis by country
7.5. Others
7.5.1. Key market trends, growth factors and opportunities
7.5.2. Market size and forecast, by region
7.5.3. Market share analysis by country
CHAPTER 8: LIVE CELL IMAGING MARKET, BY REGION
8.1. Overview
8.1.1. Market size and forecast By Region
8.2. North America
8.2.1. Key market trends, growth factors and opportunities
8.2.2. Market size and forecast, by Product Type
8.2.3. Market size and forecast, by Application
8.2.4. Market size and forecast, by Technology
8.2.5. Market size and forecast, by End User
8.2.6. Market size and forecast, by country
8.2.6.1. U.S.
8.2.6.1.1. Market size and forecast, by Product Type
8.2.6.1.2. Market size and forecast, by Application
8.2.6.1.3. Market size and forecast, by Technology
8.2.6.1.4. Market size and forecast, by End User
8.2.6.2. Canada
8.2.6.2.1. Market size and forecast, by Product Type
8.2.6.2.2. Market size and forecast, by Application
8.2.6.2.3. Market size and forecast, by Technology
8.2.6.2.4. Market size and forecast, by End User
8.2.6.3. Mexico
8.2.6.3.1. Market size and forecast, by Product Type
8.2.6.3.2. Market size and forecast, by Application
8.2.6.3.3. Market size and forecast, by Technology
8.2.6.3.4. Market size and forecast, by End User
8.3. Europe
8.3.1. Key market trends, growth factors and opportunities
8.3.2. Market size and forecast, by Product Type
8.3.3. Market size and forecast, by Application
8.3.4. Market size and forecast, by Technology
8.3.5. Market size and forecast, by End User
8.3.6. Market size and forecast, by country
8.3.6.1. Germany
8.3.6.1.1. Market size and forecast, by Product Type
8.3.6.1.2. Market size and forecast, by Application
8.3.6.1.3. Market size and forecast, by Technology
8.3.6.1.4. Market size and forecast, by End User
8.3.6.2. France
8.3.6.2.1. Market size and forecast, by Product Type
8.3.6.2.2. Market size and forecast, by Application
8.3.6.2.3. Market size and forecast, by Technology
8.3.6.2.4. Market size and forecast, by End User
8.3.6.3. UK
8.3.6.3.1. Market size and forecast, by Product Type
8.3.6.3.2. Market size and forecast, by Application
8.3.6.3.3. Market size and forecast, by Technology
8.3.6.3.4. Market size and forecast, by End User
8.3.6.4. Italy
8.3.6.4.1. Market size and forecast, by Product Type
8.3.6.4.2. Market size and forecast, by Application
8.3.6.4.3. Market size and forecast, by Technology
8.3.6.4.4. Market size and forecast, by End User
8.3.6.5. Spain
8.3.6.5.1. Market size and forecast, by Product Type
8.3.6.5.2. Market size and forecast, by Application
8.3.6.5.3. Market size and forecast, by Technology
8.3.6.5.4. Market size and forecast, by End User
8.3.6.6. Rest of Europe
8.3.6.6.1. Market size and forecast, by Product Type
8.3.6.6.2. Market size and forecast, by Application
8.3.6.6.3. Market size and forecast, by Technology
8.3.6.6.4. Market size and forecast, by End User
8.4. Asia-Pacific
8.4.1. Key market trends, growth factors and opportunities
8.4.2. Market size and forecast, by Product Type
8.4.3. Market size and forecast, by Application
8.4.4. Market size and forecast, by Technology
8.4.5. Market size and forecast, by End User
8.4.6. Market size and forecast, by country
8.4.6.1. Japan
8.4.6.1.1. Market size and forecast, by Product Type
8.4.6.1.2. Market size and forecast, by Application
8.4.6.1.3. Market size and forecast, by Technology
8.4.6.1.4. Market size and forecast, by End User
8.4.6.2. China
8.4.6.2.1. Market size and forecast, by Product Type
8.4.6.2.2. Market size and forecast, by Application
8.4.6.2.3. Market size and forecast, by Technology
8.4.6.2.4. Market size and forecast, by End User
8.4.6.3. India
8.4.6.3.1. Market size and forecast, by Product Type
8.4.6.3.2. Market size and forecast, by Application
8.4.6.3.3. Market size and forecast, by Technology
8.4.6.3.4. Market size and forecast, by End User
8.4.6.4. Australia
8.4.6.4.1. Market size and forecast, by Product Type
8.4.6.4.2. Market size and forecast, by Application
8.4.6.4.3. Market size and forecast, by Technology
8.4.6.4.4. Market size and forecast, by End User
8.4.6.5. South Korea
8.4.6.5.1. Market size and forecast, by Product Type
8.4.6.5.2. Market size and forecast, by Application
8.4.6.5.3. Market size and forecast, by Technology
8.4.6.5.4. Market size and forecast, by End User
8.4.6.6. Rest of Asia-Pacific
8.4.6.6.1. Market size and forecast, by Product Type
8.4.6.6.2. Market size and forecast, by Application
8.4.6.6.3. Market size and forecast, by Technology
8.4.6.6.4. Market size and forecast, by End User
8.5. LAMEA
8.5.1. Key market trends, growth factors and opportunities
8.5.2. Market size and forecast, by Product Type
8.5.3. Market size and forecast, by Application
8.5.4. Market size and forecast, by Technology
8.5.5. Market size and forecast, by End User
8.5.6. Market size and forecast, by country
8.5.6.1. Brazil
8.5.6.1.1. Market size and forecast, by Product Type
8.5.6.1.2. Market size and forecast, by Application
8.5.6.1.3. Market size and forecast, by Technology
8.5.6.1.4. Market size and forecast, by End User
8.5.6.2. Saudi Arabia
8.5.6.2.1. Market size and forecast, by Product Type
8.5.6.2.2. Market size and forecast, by Application
8.5.6.2.3. Market size and forecast, by Technology
8.5.6.2.4. Market size and forecast, by End User
8.5.6.3. South Africa
8.5.6.3.1. Market size and forecast, by Product Type
8.5.6.3.2. Market size and forecast, by Application
8.5.6.3.3. Market size and forecast, by Technology
8.5.6.3.4. Market size and forecast, by End User
8.5.6.4. Rest of LAMEA
8.5.6.4.1. Market size and forecast, by Product Type
8.5.6.4.2. Market size and forecast, by Application
8.5.6.4.3. Market size and forecast, by Technology
8.5.6.4.4. Market size and forecast, by End User
CHAPTER 9: COMPETITIVE LANDSCAPE
9.1. Introduction
9.2. Top winning strategies
9.3. Product mapping of top 10 player
9.4. Competitive dashboard
9.5. Competitive heatmap
9.6. Top player positioning, 2022
CHAPTER 10: COMPANY PROFILES
10.1. PerkinElmer, Inc.
10.1.1. Company overview
10.1.2. Key executives
10.1.3. Company snapshot
10.1.4. Operating business segments
10.1.5. Product portfolio
10.1.6. Business performance
10.2. Danaher Corporation
10.2.1. Company overview
10.2.2. Key executives
10.2.3. Company snapshot
10.2.4. Operating business segments
10.2.5. Product portfolio
10.2.6. Business performance
10.2.7. Key strategic moves and developments
10.3. Thermo Fisher Scientific Inc.
10.3.1. Company overview
10.3.2. Key executives
10.3.3. Company snapshot
10.3.4. Operating business segments
10.3.5. Product portfolio
10.3.6. Business performance
10.4. Agilent Technologies, Inc.
10.4.1. Company overview
10.4.2. Key executives
10.4.3. Company snapshot
10.4.4. Operating business segments
10.4.5. Product portfolio
10.4.6. Business performance
10.5. Etaluma, Inc.
10.5.1. Company overview
10.5.2. Key executives
10.5.3. Company snapshot
10.5.4. Operating business segments
10.5.5. Product portfolio
10.5.6. Key strategic moves and developments
10.6. Bruker Corporation
10.6.1. Company overview
10.6.2. Key executives
10.6.3. Company snapshot
10.6.4. Operating business segments
10.6.5. Product portfolio
10.6.6. Business performance
10.6.7. Key strategic moves and developments
10.7. Merck KGaA
10.7.1. Company overview
10.7.2. Key executives
10.7.3. Company snapshot
10.7.4. Operating business segments
10.7.5. Product portfolio
10.7.6. Business performance
10.8. Sartorius AG
10.8.1. Company overview
10.8.2. Key executives
10.8.3. Company snapshot
10.8.4. Operating business segments
10.8.5. Product portfolio
10.8.6. Business performance
10.8.7. Key strategic moves and developments
10.9. Carl Zeiss AG
10.9.1. Company overview
10.9.2. Key executives
10.9.3. Company snapshot
10.9.4. Operating business segments
10.9.5. Product portfolio
10.9.6. Business performance
10.10. Nikon Corporation
10.10.1. Company overview
10.10.2. Key executives
10.10.3. Company snapshot
10.10.4. Operating business segments
10.10.5. Product portfolio
10.10.6. Business performance
| ※参考情報 ライブセルイメージングとは、生きた細胞を観察する技術であり、細胞内の動態や相互作用をリアルタイムで視覚化することができます。この技術は、細胞生物学や分子生物学の研究において重要なツールとなっており、細胞の挙動や機能を理解するために広く用いられています。また、病気のメカニズムの解明や新たな治療法の開発にも寄与しています。 ライブセルイメージングには、様々な種類があります。代表的なものには、蛍光顕微鏡を用いた手法があります。蛍光顕微鏡では、特定の蛍光色素で標識された分子を追跡することができ、細胞内での分子の動きや相互作用を観察できます。さらに、共焦点顕微鏡や超解像顕微鏡などの高解像度技術も活用され、細胞内部の微細構造まで観察することが可能です。 リアルタイムでの観察を可能にするため、非侵襲的な条件で実験を行うことが求められます。生きた細胞を扱うライブセルイメージングでは、環境条件を適切に制御する必要があります。たとえば、温度、二酸化炭素濃度、栄養素の供給などを維持するインキュベーター内で実験を行うことが一般的です。これにより、細胞が健康な状態で観察され、正確なデータを取得することができます。 ライブセルイメージングの用途は多岐にわたります。例えば、細胞分裂の過程を観察することで、がん細胞の増殖メカニズムを解明したり、神経細胞間のシナプス形成の動態を研究することができます。また、細胞の運動や形態変化、細胞内カルシウム濃度の変動などをリアルタイムで観察することにより、細胞の生理学的な反応を詳細に理解する助けとなります。 さらに、ライブセルイメージングは創薬研究においても重要な役割を果たしています。新しい薬剤を開発する際、薬剤が細胞内でどのように作用するかを観察することで、より効果的な治療法を見出すことができます。また、特定の病状に対する反応をリアルタイムで把握することで、個別化医療の発展にも貢献しています。 関連技術としては、フルオロフォースイッチングやマルチフォトン顕微鏡、光干渉断層撮影（OCT）などがあります。これらの技術は、異なる視点や解像度で細胞の状態を観察する手段を提供し、ライブセルイメージングの情報を補完します。また、画像処理技術の進化により、取得したデータを解析する際の精度や効率も向上しています。 最近では、AIや機械学習を用いた画像解析の発展も注目されています。大量のデータを迅速に処理し、細胞の挙動やパターンを特定することが可能です。これにより、研究者はより多くのデータを短時間で分析し、洞察を得ることができるようになります。このような技術の導入により、ライブセルイメージングはより効率的で精度の高い研究を実現しています。 まとめると、ライブセルイメージングは生きた細胞のダイナミクスをリアルタイムで観察するための強力な技術であり、多くの生物学的研究や医療の分野で応用されています。さまざまな技術と相まって、細胞の理解を深め、新たな発見をもたらすために日々進化を続けています。この技術のさらなる進展により、私たちの生命科学の理解は、ますます深まっていくことでしょう。 |
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
